Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ECL1i, d(LGTFLKC), a novel, small peptide that specifically inhibits CCL2-dependent migration.
Auvynet C, Baudesson de Chanville C, Hermand P, Dorgham K, Piesse C, Pouchy C, Carlier L, Poupel L, Barthélémy S, Felouzis V, Lacombe C, Sagan S, Chemtob S, Quiniou C, Salomon B, Deterre P, Sennlaub F, Combadière C. Auvynet C, et al. Among authors: piesse c. FASEB J. 2016 Jun;30(6):2370-81. doi: 10.1096/fj.201500116. Epub 2016 Mar 15. FASEB J. 2016. PMID: 26979087
ECL1i is a promising new agent in therapeutic development, and it may, by its selective effect, increase our understanding of CCR2 signaling pathways and functions.-Auvynet, C., Baudesson de Chanville, C., Hermand, P., Dorgham, K., Piesse, C., Pouchy, …
ECL1i is a promising new agent in therapeutic development, and it may, by its selective effect, increase our understanding of CCR2 signaling …
Characterization of a New Immunosuppressive and Antimicrobial Peptide, DRS-DA2, Isolated from the Mexican Frog, Pachymedusa dacnicolor.
Lacombe C, Aleman-Navaro E, Drujon T, Martinez-Osorio V, Sachon E, Melchy-Pérez E, Carlier L, Fajardo Brigido LE, Fleury Y, Piesse C, Gutiérrez-Escobedo G, De Las Peñas A, Castaño I, Desriac F, Beristain-Hernandez JL, Combadiere C, Rosenstein Y, Auvynet C. Lacombe C, et al. Among authors: piesse c. Int J Inflam. 2024 Jan 13;2024:2205864. doi: 10.1155/2024/2205864. eCollection 2024. Int J Inflam. 2024. PMID: 38250663 Free PMC article.
Peptidoglycan potentiates the membrane disrupting effect of the carboxyamidated form of DMS-DA6, a Gram-positive selective antimicrobial peptide isolated from Pachymedusa dacnicolor skin.
Cardon S, Sachon E, Carlier L, Drujon T, Walrant A, Alemán-Navarro E, Martínez-Osorio V, Guianvarc'h D, Sagan S, Fleury Y, Marquant R, Piesse C, Rosenstein Y, Auvynet C, Lacombe C. Cardon S, et al. Among authors: piesse c. PLoS One. 2018 Oct 16;13(10):e0205727. doi: 10.1371/journal.pone.0205727. eCollection 2018. PLoS One. 2018. PMID: 30325956 Free PMC article.
Reverse Immunology Approach to Define a New HIV-gp41-Neutralizing Epitope.
Dorgham K, Pietrancosta N, Affoune A, Lucar O, Bouceba T, Chardonnet S, Pionneau C, Piesse C, Sterlin D, Guardado-Calvo P, Karoyan P, Debré P, Gorochov G, Vieillard V. Dorgham K, et al. Among authors: piesse c. J Immunol Res. 2019 Mar 24;2019:9804584. doi: 10.1155/2019/9804584. eCollection 2019. J Immunol Res. 2019. PMID: 31019982 Free PMC article.
27 results